TRIG to acquire 213MW Jadraas wind farm in Sweden

TRIG to acquire 213MW Jadraas wind farm in Sweden

Wind industry news : British investment trust The Renewables Infrastructure Group (TRIG) has signed a deal worth €207 million to acquire the operational 212.85MW Jadraas wind farm from Arise and Sydvastanvind, two Swedish firms controlled by Platina Energy Partners. The Jadraas wind farm built near Ockelbo, north of Stockholm, is equipped with 66 V-112 turbines […]

Calliditas Therapeutics initiates Phase 3 NEFIGARD trial for Nefecon to treat IgA nephropathy

Calliditas Therapeutics initiates Phase 3 NEFIGARD trial for Nefecon to treat IgA nephropathy

Swedish pharmaceutical company Calliditas Therapeutics has initiated the Phase 3 NEFIGARD trial to evaluate its lead drug candidate, Nefecon, for treating IgA nephropathy (IgAN), commonly known as Berger’s disease. The NEFIGARD trial marks a significant step for Calliditas Therapeutics as it begins enrolling patients for a late-stage study designed to assess the effectiveness of Nefecon […]

Modus Therapeutics secures $15.7m for sickle cell disease drug development

Modus Therapeutics secures $15.7m for sickle cell disease drug development

Modus Therapeutics, a Swedish biotech firm specializing in sickle cell disease therapies, has successfully raised SEK 140 million ($15.76 million) in a funding round spearheaded by HealthCap, a leading European venture capital firm known for investing in innovative therapies for diseases with significant unmet medical needs. The Series A funding round saw HealthCap contribute SEK […]

Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855m to enhance rare disease treatment options

Alexion Pharmaceuticals to acquire Wilson Therapeutics for $855m to enhance rare disease treatment options

In a significant move to expand its rare disease drug portfolio, U.S.-based Alexion Pharmaceuticals has announced an all-cash acquisition of Swedish pharmaceutical company Wilson Therapeutics for SEK7.1 billion ($855 million). This strategic acquisition is set to significantly bolster Alexion’s offerings in the rare disease sector, particularly in treating Wilson disease, a rare copper-mediated disorder. Details […]

Cloetta to give up on “unprofitable” Candyking business in Poland

Cloetta to give up on “unprofitable” Candyking business in Poland

Confectionery industry news : Sweden-based confectionery manufacturer Cloetta has revealed its intentions to exit its Candyking business in Poland after finding it to be unprofitable. Candyking is a Swedish company that manufactures and markets pick and mix confectionery products across Sweden, Finland, the United Kingdom, Norway, Estonia, Latvia, Lithuania, Poland, Denmark, and Ireland. Last year, […]

1 8 9 10